CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Abatacept

Last Updated: November 29, 2012
Result type: Reports
Project Number: SR0299
Product Line: Common Drug Review

Generic Name: Abatacept

Brand Name: Orencia

Manufacturer: Bristol-Myers Squibb Canada

Indications: Arthritis, Rheumatoid

Submission Type: Pre-NOC

Project Status: Complete

Date Recommendation Issued: July 18, 2013

Recommendation Type: List with clinical criteria and/or conditions